The romantic thriller sequel Awarapan 2 continues to maintain a stable presence at the box office as its theatrical run reaches the twelfth day of its fourth week. Headlined by actor Emraan Hashmi, the film is steadily working its way toward a domestic net collection milestone of Rs 145 crore in the Indian market.

Industry observers note that the picture has displayed consistent, though measured, holding power during its extended run. With its initial weeks now in the past, the production is striving to accumulate maximum revenue before a major market shift takes place later this week.

That upcoming shift arrives in the form of Toxic, a highly anticipated cinematic project starring Kannada star Yash, which is scheduled to premiere in cinemas on August 26. The impending arrival of this formidable competitor places the Hashmi vehicle in a race against time to solidify its final box office standing and approach its target figures.

Sequels and follow-ups to cult classics often face distinct box office trajectories, balancing initial fan enthusiasm with the challenge of sustaining momentum against newer releases. Awarapan 2 has relied on its established brand value and the enduring popularity of its lead star to retain audience interest past the typical multi-week drop-off period.

As exhibition windows narrow and major new titles prepare to capture screen space across the country, trade analysts continue to monitor the daily tallies of the sequel. Whether the feature can successfully cross its projected domestic benchmark before the new competition alters the theatrical landscape remains the central focus for box office watchers this week.

Reporting based on coverage first published by The Times of India. Read the original report at The Times of India.